Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Update: D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma [Phase 3]
Phase 3 trial investigating D2 resection with HIPEC in locally advanced gastric carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) [Phase 1, Phase 2]
Phase 1/2 study evaluating multiple immunotherapy-based combinations in locally advanced unresectable or metastatic gastric/GEJ cancer and e…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies [Phase 2]
Phase 2 clinical trial evaluating a PD-1–blocking monoclonal antibody in combination with a metabolic modulator for several solid tumors is …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating Suratadenoturev (OBP-301) in combination with pembrolizumab for esophagogastric adenocarcinoma; recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas [Phase 2]
Phase 2 clinical trial evaluating Denikitug (GS-1811) alone or with nivolumab or chemotherapy in adults with metastatic gastric, gastroesoph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ [Phase 2]
This Phase 2 trial investigates adebrelimab with nab-paclitaxel, oxaliplatin and tegafur (AOS) as perioperative therapy for locally advanced…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating ASP2138 given alone or with other cancer therapies in adults with gastric adenocarcinoma, gastroesophage…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers [Phase 1]
This update details a Phase 1 study evaluating DISP-10 in advanced gastrointestinal cancers, with the trial currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial updating the design of a study comparing subcutaneous tislelizumab versus intravenous tislelizumab plus chemotherapy in unrese…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating nivolumab added to standard therapy for advanced gastric and esophageal adenocarcinomas, incl…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ [Phase 2]
Sintilimab plus chemotherapy is being evaluated as adjuvant therapy in a Phase 2 study for gastric adenocarcinoma and esophagogastric juncti…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Laparoscopic Staging for Stage III Gastric Cancer [NA]
Ongoing clinical trial evaluating laparoscopic staging for stage III gastric cancer; the study is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ASP546C in adults with gastric/GEJ adenocarcinoma, pancreatic adenocarcinoma, or other solid tumors is…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the dose of Zongertinib used alone or with other therapies in HER2-positive metastatic cancers, including breas…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update indicates a Phase 1/2 study of BHB810 in advanced gastric and GEJ adenocarcinoma, with the trial currently not yet rec…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]
An ongoing Phase 1 trial is evaluating BL-M05D1 in patients with solid tumors, assessing safety, tolerability, pharmacokinetics, and prelimi…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating trastuzumab deruxtecan in combination with nivolumab, capecitabine, and oxaliplatin for HER2-low gastric and ga…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors [Phase 1]
Plexium, Inc. is conducting a first-in-human Phase 1 study of PLX-61639 in locally advanced or metastatic solid tumors, and the trial is cur…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management
This clinical trial update analyzes the costs of opportunistic upper gastrointestinal endoscopy and the economic burden of managing gastric …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical study of regorafenib and nivolumab plus chemotherapy for gastric and gastroesophageal junction adenocarcinoma (an…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . [Phase 1, Phase 2]
Clinical trial update for a three-drug combination (ramucirumab, nanoliposomal irinotecan, and trifluridine/tipiracil) being studied in seco…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients With HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating trastuzumab deruxtecan, with or without capecitabine and durvalumab, as neoa…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study [Phase 2]
A Phase 2 trial (ROBO-CHIP) from Mayo Clinic is evaluating robotic cytoreduction followed by hyperthermic intraperitoneal chemotherapy for g…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma [Phase 3]
A Phase 3 trial is evaluating mFOLFIRINOX versus mFOLFOX with or without nivolumab for HER2-negative advanced, unresectable, or metastatic e…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France
An observational study in France evaluating outcomes for patients with advanced gastric and esophageal cancers treated with nivolumab in com…